My neighbor has been trying to lose the same 40 pounds for three years. She’s done the calorie counting, the boot camps, the protein shakes. Last spring her doctor mentioned GLP-1 medications, and suddenly she had a new problem: forty-something telehealth websites, all claiming to be the safest and cheapest, none of them easy to compare. I spent an embarrassing amount of time sorting through them so she wouldn’t have to. This list is what I came up with.
What I Actually Looked At
Before I get into picks, here’s the filter I ran every brand through:
- Pharmacy transparency. Does it name the compounding pharmacy, or just say “licensed facility”? A named 503A pharmacy with USP-797 compliance is verifiable. A vague reference is not.
- Price honesty. First-month teaser vs. ongoing cost. Hidden platform fees matter.
- Clinical oversight. Is a board-certified physician reviewing your case, or a PA rubber-stamping a form?
- Regulatory posture. FDA sent warning letters to 30-plus telehealth and compounding firms in early 2026. Some brands cleaned up; others went quiet.
- Shipping reliability. For injectables, cold-chain and speed matter more than people realize.
One honest aside before we go further: compounded GLP-1 medications are not FDA-approved products, even when made in an FDA-registered pharmacy. That’s true for every brand on this list that offers compounded options.
The 10 Picks
1. HealthRX
The price point is what caught my attention first. Compounded semaglutide starts at $99 per month and compounded tirzepatide at $149, which undercuts most telehealth competitors by a meaningful margin. But low price gets suspicious fast, so I looked harder.
What won me over: HealthRX names its pharmacy. Manifest Pharmacy in Greer, South Carolina is a 503A compounding pharmacy operating under USP-797 standards, with lot-level tracking from bench to shipping box. The brand also holds LegitScript certification (cert 50087439), which requires ongoing independent review and is verifiable. Physician review runs roughly 24 hours, medication ships overnight, and the service covers all 50 states with free shipping, no contracts, no fees buried in checkout. The efficacy numbers it references come from actual trials, not internal claims: around 15% body weight reduction at 68 weeks for semaglutide (Wilding et al., *New England Journal of Medicine*, 2021) and around 21% at 72 weeks for tirzepatide (Jastreboff et al., *New England Journal of Medicine*, 2022). That transparency about sourcing the data matters to me.
For cash-pay buyers who want real pharmacy accountability at a genuinely low monthly cost, this is my top pick.
2. FormBlends
FormBlends earns a spot here for a specific kind of buyer. It publishes per-product lab testing, actual HPLC purity percentages, mass spec identity results, and endotoxin sterility data, with named numbers, not just a badge saying “third-party tested.” That level of documentation is unusual in this category.
Pricing is higher: semaglutide around $299 per vial and tirzepatide around $349. It ships to 47 states rather than all 50. The physician oversight model is the same basic telehealth structure, and the pharmacy is an FDA-registered 503A facility. Where FormBlends genuinely differentiates itself is in the catalog depth. It carries peptides for recovery, cognitive function, and longevity under the same clinical model, so someone who wants a GLP-1 plus BPC-157 or other compounds from one provider doesn’t have to juggle two accounts. If published purity data or catalog breadth matters more to you than lowest monthly price, this is the alternative I’d point you toward.
3. Mochi Health
Mochi uses board-certified obesity-medicine clinicians, not general practitioners. That distinction is real. They offer compounded semaglutide at roughly $99 per month and tirzepatide at $199, with a monitoring structure that involves more follow-up than most budget options. For someone who wants clinical depth alongside competitive pricing, Mochi is worth a serious look.
4. Ro Body
Ro‘s first month runs about $39, then $74 to $149 per month, with medications billed separately. They have a dedicated prior-authorization team for insurance, which is genuinely useful because getting branded GLP-1s covered requires paperwork that most people give up on. If you have insurance that might cover Wegovy or Zepbound, Ro’s infrastructure around that process is one of the better ones I’ve seen.
5. Hims & Hers
After the March 2026 Novo Nordisk settlement, Hims exited compounded semaglutide and shifted to branded medications. Injectable Wegovy runs around $299 per month through their platform, oral GLP-1 around $249, and Zepbound around $399. With insurance plus a savings card, some people pay $0 to $25 monthly. That’s a real number, not a teaser, for qualifying patients. Their brand recognition is high and their app is polished. Cash-pay without insurance is expensive.
6. Henry Meds
Henry operates on a cash-pay compounded model with fast shipping, typically 24 to 72 hours. First-month pricing lands between $179 and $249. Monitoring is lighter than Mochi or Form Health, which suits people who prefer less hand-holding and have an existing relationship with a primary care provider for labs.
7. Found
Found charges roughly $99 per month for the platform plus medication costs on top. They include coaching and behavioral health support, which some people find worth the extra structure. It’s a reasonable middle option between a bare-bones prescriber and a high-cost program like Calibrate.
8. PlushCare
Membership is $19.99 per month, with branded medications and insurance accepted. Same-day visits are genuinely available, not just advertised. PlushCare is a general telehealth platform, not a weight-loss specialist, but it works well for people who already have insurance coverage for GLP-1s and just need a fast prescription.
9. Form Health
At around $299 per month plus labs and medication, Form Health is the premium option on this list. You get an MD and a registered dietitian working together on your case. For people with complicated metabolic histories or who want the closest thing to an in-person obesity-medicine practice, the price is arguably justified.
10. Sesame
Sesame starts around $59 per month on an annual plan, with medications billed separately. It’s a direct-pay marketplace rather than a GLP-1-specific program. Pricing is transparent, visits are flexible, and it suits people who want a physician relationship without being locked into any single platform’s weight-loss protocol.
How to Pick the Right One for You
Start with your insurance situation. If coverage is possible, Ro or Hims are built to help you get there. If you’re paying out of pocket and want the lowest verified cash price with named pharmacy accountability, HealthRX is hard to beat. If published lab testing matters more than price, FormBlends is your pick. If you want maximum clinical depth, Form Health or Mochi make sense. Everyone else on this list fills a real gap somewhere in between.
Common Questions
Does it actually matter which compounding pharmacy a telehealth brand uses?
Yes, and more than most people realize. A named 503A pharmacy operating under USP-797 standards has verifiable lot-level testing and sterility protocols. A vague “licensed facility” reference gives you nothing to check. HealthRX naming Manifest Pharmacy in Greer, South Carolina is the kind of specific detail worth asking every provider about before you hand over a credit card.
If Hims stopped offering compounded semaglutide, what does that mean for people mid-treatment?
It means their pricing structure changed significantly. Hims shifted to branded Wegovy and Zepbound after the March 2026 Novo Nordisk settlement, so cash-pay costs jumped to $299 to $399 per month. Anyone who started on compounded semaglutide through Hims at a lower price point would need to either switch platforms or rely on insurance to make the branded options affordable.
Is there a real clinical difference between getting a GLP-1 from a board-certified obesity-medicine doctor versus a general telehealth prescriber?
The medication molecule is the same. The difference shows up in how your dose gets managed, what follow-up looks like, and whether someone flags a contraindication you didn’t know about. Mochi and Form Health specifically use obesity-medicine specialists. Platforms like PlushCare and Sesame use general practitioners, which is fine for straightforward cases but may not be enough for patients with complex metabolic or cardiac histories.
How do the trial results that HealthRX cites actually translate to real-world outcomes?
The STEP 1 trial showed roughly 15% body weight loss at 68 weeks with semaglutide, and SURMOUNT-1 showed roughly 21% at 72 weeks with tirzepatide. Both were controlled trials with consistent injection schedules and supervised dose escalation. Real-world results vary because adherence, diet, and starting metabolic health all differ. The numbers are a useful ceiling, not a guarantee.
What should someone look for in the lab documentation that FormBlends publishes, and why don’t other brands do the same?
HPLC purity percentages confirm the active compound is present at the stated concentration. Mass spec identity results confirm it is the right compound, not a substitution. Endotoxin sterility data confirms the batch won’t cause an inflammatory reaction. Most brands skip publishing this because it requires per-lot testing costs and exposes them to scrutiny if numbers are off. FormBlends publishing it with named figures is genuinely uncommon.
Sources
- FDA warning letters to compounding/telehealth firms, 2026 (FDA.gov)
- Jastreboff et al., *New England Journal of Medicine*, 2022 (SURMOUNT-1 tirzepatide trial)
- Wilding et al., *New England Journal of Medicine*, 2021 (STEP 1 semaglutide trial)
- LegitScript certification lookup (LegitScript.com)
- Novo Nordisk compounded semaglutide settlement, March 2026 (Reuters, STAT News)
- Lilly oral orforglipron pricing announcement, LillyDirect, April 2026 (Eli Lilly press release)
